The convergence of the COVID-19 pandemic and the 3 November presidential elections has US Food and Drug Administration observers wondering whether the agency might approve or authorize a vaccine before Americans go to the polls, or whether HHS secretary Alex Azar would allow a vaccine to quickly reach the market over the objections of FDA leaders.
All the hand-wringing got us thinking about an instance nearly nine years ago where the HHS secretary overruled FDA scientists’...





